Eva Barnett
Patrimonio netto: 6 M $ in data 31/07/2026
Patrimonio netto: 6 M $ in data 31/07/2026
Eva Renee Barnett worked at Eli Lilly & Co. from 2011 to 2012 as Chief Financial Officer-Austria & Switzerland.
From 2015 to 2021, worked at AbleTo, Inc. as Chief Integration Officer.
From 2021 to 2025, worked at Immunovant, Inc. as Chief Financial & Accounting Officer.
Education includes undergraduate studies at DePauw University and an MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOVANT INC 0,08% | 30/06/2026 | 157.761 ( 0,08% ) | 6 M $ | 31/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOVANT, INC. | Direttore Finanziario/CFO | 20/04/2025 |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Direttore Finanziario/CFO | 01/03/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/08/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale